VERTEX PHARMACEUTICAL earnings per share and revenue

VX1 earnings per share for the last quarter are 3.93 EUR whereas the estimation was 3.66 EUR which accounts for 7.41% surprise. Company revenue for the same period amounts to 2.49 B EUR despite the estimated figure of 2.41 B EUR. Estimated earnings per share for the next quarter are 3.90 EUR, and revenue is expected to reach 2.67 B EUR. Also watch annual changes over time to get a bigger picture of VX1 earnings per share and revenue dynamics.